by ptfadmin | Jun 27, 2023 | Health Tips
by John Baur, PT, OCS, FAAOMPT
Acetaminophen (APAP) is a commonly used over-the-counter pain reliever that can cause liver damage when taken in high doses. The common brand name for acetaminophen (APAP) is Tylenol and acute liver injury caused by APAP overdose is a serious medical condition that can lead to liver failure and death. Probiotics are live microorganisms that can provide health benefits when consumed in adequate amounts. Bacillus spp. spores are a type of probiotic that have been shown to modulate the gut microbiota and improve overall health. In this report, we will discuss a study that investigated the effects of a probiotic containing Bacillus spp. spores on a rat model of APAP-induced acute liver injury.
Methods
The study used a rat model of APAP-induced acute liver injury. The rats were divided into four groups: a control group, an APAP group, an APAP group treated with the probiotic, and an APAP group treated with N-acetylcysteine (NAC), a standard treatment for APAP-induced liver injury. The probiotic contained Bacillus spp. spores.
The rats were treated with the probiotic or NAC for a period of 3 days. The severity of liver injury was assessed by measuring levels of liver enzymes in the blood and examining liver tissue for signs of damage.
Results
The study found that treatment with the probiotic containing Bacillus spp. spores protected against APAP-induced acute liver injury in rats. The probiotic significantly reduced levels of liver enzymes in the blood and reduced signs of liver damage in the liver tissue. The protective effects of the probiotic were comparable to those of NAC, the standard treatment for APAP-induced liver injury.
The study also found that the probiotic increased the abundance of beneficial bacteria in the gut microbiota, which may have contributed to its protective effects on the liver.
Conclusion
The study suggests that treatment with a probiotic containing Bacillus spp. spores can protect against APAP-induced acute liver injury in rats. The probiotic reduced levels of liver enzymes in the blood and reduced signs of liver damage in the liver tissue. These findings suggest that Bacillus spp. spores could be a promising treatment option for APAP-induced liver injury in humans. Further research is needed to confirm these findings in human clinical trials, but the study provides a promising avenue for future research in the field of probiotics and liver health.
Physical Therapy First recognizes the importance staying well-informed with the latest health and wellness topics that affect our patients. Megasporebiotic made by Microbiome Labs (microbiomelabs.com) is the first spore-base probiotic with research which supports it use for Acetaminophen (APAP)-induced acute liver injury and many other health conditions.
Reference
Probiotic Bacillus Spores Protect Against Acetaminophen Induced Acute Liver Injury in Rats.Neag MA, Catinean A, Muntean DM, Pop MR, Bocsan CI, Botan EC, Buzoianu AD.Nutrients. 2020 Feb 27;12(3):632. doi: 10.3390/nu12030632.
by ptfadmin | Jun 12, 2023 | Health Tips
by John Baur, PT, OCS, FAAOMPT
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the colon and rectum. It is characterized by symptoms such as abdominal pain, diarrhea, and rectal bleeding. While the exact cause of UC is unknown, it is believed to be related to an imbalance in the gut microbiota and inflammation. Probiotics are live microorganisms that can provide health benefits when consumed in adequate amounts. Bacillus spp. spores are a type of probiotic that have been shown to modulate the gut microbiota and improve overall health. In this report, we will discuss a study that investigated the effects of a probiotic containing Bacillus spp. spores, amino acids, and immunoglobulins on a rat model of UC.
Methods
The study used a rat model of UC induced by dextran sulfate sodium (DSS). The rats were divided into four groups: a control group, a DSS group, a DSS group treated with the probiotic, and a DSS group treated with mesalazine, a standard treatment for UC. The probiotic contained Bacillus spp. spores, amino acids, and immunoglobulins.
The rats were treated with the probiotic or mesalazine for a period of 14 days. The severity of UC was assessed by measuring body weight, stool consistency, and rectal bleeding. The inflammatory response was assessed by measuring levels of inflammatory cytokines in the colon tissue.
Results
The study found that treatment with the probiotic containing Bacillus spp. spores, amino acids, and immunoglobulins exerted protective effects on the rat model of UC. The probiotic significantly reduced the severity of UC, as evidenced by improvements in body weight, stool consistency, and rectal bleeding. The probiotic also reduced the inflammatory response, as evidenced by reductions in levels of inflammatory cytokines in the colon tissue.
Conclusion
The study suggests that treatment with a probiotic containing Bacillus spp. spores, amino acids, and immunoglobulins can exert protective effects on a rat model of UC. The probiotic reduced the severity of UC and the inflammatory response, suggesting that it could be a promising treatment option for UC. Further research is needed to confirm these findings in human clinical trials, but the study provides a promising avenue for future research in the field of probiotics and UC treatment.
Physical Therapy First recognizes the importance staying well-informed with the latest health and wellness topics that affect our patients. Megasporebiotic made by Microbiome Labs (microbiomelabs.com) is the first spore-base probiotic with research which supports it use for Ulcerative colitis (UC) and many other health conditions.
Reference
Probiotic Bacillus Spores Together with Amino Acids and Immunoglobulins Exert Protective Effects on a Rat Model of Ulcerative Colitis. Catinean A, Neag MA, Krishnan K, Muntean DM, Bocsan CI, Pop RM, Mitre AO, Melincovici CS, Buzoianu AD. Nutrients. 2020 Nov 24;12(12):3607. doi: 10.3390/nu12123607.
by ptfadmin | Jun 5, 2023 | Health Tips
By John Baur, PT, DPT, OCS, FAAOMPT
The gut microbiota plays a crucial role in maintaining overall health and well-being. An imbalance in the gut microbiota has been linked to a variety of health problems, including gastrointestinal disorders, metabolic disorders, and immune dysfunction. Probiotics are live microorganisms that can provide health benefits when consumed in adequate amounts. Bacillus spp. spores are a type of probiotic that have been shown to modulate the gut microbiota and improve overall health. In this report, we will discuss a study that investigated the effects of a spore-based probiotic containing five strains of Bacillus on the gut microbiota in a SHIME® model of the human gastrointestinal system.
The study used a SHIME® (Simulator of the Human Intestinal Microbial Ecosystem) model to simulate the human gastrointestinal system. The SHIME® model consists of five compartments that simulate different parts of the gastrointestinal tract, including the stomach, small intestine, and colon. The model was inoculated with fecal samples from healthy human donors to establish a complex and diverse gut microbiota.
The spore-based probiotic containing five strains of Bacillus (Bacillus subtilis, Bacillus clausii, Bacillus coagulans, Bacillus licheniformis, and Bacillus pumilus) was added to the SHIME® model for a period of 21 days. The metabolic activity and community composition of the gut microbiota were analyzed before and after treatment with the probiotic.
The study found that treatment with the spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in the SHIME® model. Specifically, the probiotic increased the production of short-chain fatty acids (SCFAs), which are important for maintaining gut health and reducing inflammation. The probiotic also increased the abundance of beneficial bacteria such as Bifidobacterium and Lactobacillus, while reducing the abundance of harmful bacteria such as Clostridium difficile.
In conclusion, the study provides evidence that treatment with a spore-based probiotic containing five strains of Bacillus can induce changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system. The probiotic increased the production of short-chain fatty acids and the abundance of beneficial bacteria, while reducing the abundance of harmful bacteria. These findings suggest that Bacillus spp. spores could be a promising treatment option for a variety of health problems related to gut microbiota imbalance, including gastrointestinal disorders, metabolic disorders, and immune dysfunction. Further research is needed to confirm these findings in human clinical trials, but the study provides a promising avenue for future research in the field of probiotics and gut health.
Physical Therapy First recognizes the importance staying well-informed with the latest health and wellness topics that affect our patients. Megasporebiotic made by Microbiome Labs (microbiomelabs.com) is the first spore-base probiotic with research which supports it use for maintaining gut health and reducing systemic inflammation.
Reference
Food Res Int. 2021 Nov; 149:110676. doi: 10.1016/j.foodres.2021.110676. Epub 2021 Aug 30.
Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system. Massimo Marzorati, Pieter Van den Abbeele, Sarah Bubeck, Thomas Bayne, Kiran Krishnan, Aicacia Young
by ptfadmin | May 30, 2023 | Health Tips
By John Baur, PT, DPT, OCS, FAAOMPT
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects millions of people worldwide. It is characterized by symptoms such as abdominal pain, bloating, and changes in bowel habits. While the exact cause of IBS is unknown, it is believed to be related to an imbalance in the gut microbiota and inflammation. In recent years, there has been growing interest in the use of probiotics and other microbiota-targeted therapies for the treatment of IBS. In this report, we will discuss the potential of Bacillus spp. spores as a promising treatment option for patients with IBS.
Bacillus spp. Spores and Gut Microbiota
Bacillus spp. are a group of spore-forming bacteria that are commonly found in soil and water. They are known for their ability to survive in harsh environments and have been used for centuries in traditional medicine for the treatment of various ailments. In recent years, there has been growing interest in the use of Bacillus spp. spores as a probiotic for the treatment of gastrointestinal disorders.
Studies have shown that Bacillus spp. spores have the ability to modulate the gut microbiota and reduce inflammation. They have been shown to increase the abundance of beneficial bacteria such as Bifidobacterium and Lactobacillus, while reducing the abundance of harmful bacteria such as Clostridium difficile. Bacillus spp. spores also produce short-chain fatty acids (SCFAs), which are important for maintaining gut health and reducing inflammation.
Bacillus spp. Spores and Irritable Bowel Syndrome
Several studies have investigated the potential of Bacillus spp. spores as a treatment option for patients with IBS. A randomized, double-blind, placebo-controlled trial found that a combination of Bacillus coagulans and fructooligosaccharides (FOS) significantly improved symptoms of IBS, including abdominal pain, bloating, and stool consistency. Another study found that Bacillus clausii spores significantly reduced symptoms of IBS, including abdominal pain and bloating.
The mechanism by which Bacillus spp. spores improve symptoms of IBS is not fully understood. However, it is believed that their ability to modulate the gut microbiota and reduce inflammation plays a key role. Bacillus spp. spores may also improve gut barrier function, which is important for preventing the entry of harmful bacteria and toxins into the bloodstream.
In conclusion, Bacillus spp. spores have shown promising results as a treatment option for patients with irritable bowel syndrome (IBS). Studies have shown that Bacillus spp. spores have the ability to modulate the gut microbiota and reduce inflammation, which are key factors in the development of IBS. Bacillus spp. spores have been shown to improve symptoms of IBS, including abdominal pain, bloating, and stool consistency. While more research is needed to fully understand the mechanism by which Bacillus spp. spores improve symptoms of IBS, they offer a promising treatment option for patients who do not respond to traditional therapies. Bacillus spp. spores are generally safe and well-tolerated, making them a viable option for long-term use.
Physical Therapy First recognizes the importance staying well-informed with the latest health and wellness topics that affect our patients. Megasporebiotic made by Microbiome Labs (microbiomelabs.com) is the first spore-base probiotic with research which supports it use for IBS and many other health conditions.
Reference
Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome.
Catinean A, Neag AM, Nita A, Buzea M, Buzoianu AD.Nutrients. 2019 Aug 21;11(9):1968. doi: 10.3390/nu11091968.
by ptfadmin | Jan 31, 2023 | Health Tips
by Tyler Tice, PT, DPT, MS, ATC
Introduction:
As life expectancy increases globally as modern medicine becomes more advanced, chronic diseases will affect a larger portion of our population as a result. One of the leading causes of chronic pain and disability worldwide is knee osteoarthritis (OA). Knee OA affects the entire joint and its symptoms are frequently related to physical inactivity. Currently, there are many lines of treatment that a patient with knee OA can undergo. There is substantial research supporting the use of exercise in positively impacting knee OA symptoms, however pharmacological intervention continues to be the primary form of treatment. This purpose of this article was to provide updated information regarding current treatment interventions for knee OA.
Key Treatments – Non-pharmacological
Patient education: Patient education is an essential role in decision-making, disease self-management, and medication adherence of individuals with knee OA. As healthcare providers, it’s essential to develop a clear understanding of the disease to effectively direct patients towards high-quality health information. Some key messages that should be included in your education should be: 1) regular physical activity and individualized exercise programs can reduce pain, prevent worsening, and improve daily function in OA; 2) losing weight for overweight individuals is a benefit, as well as maintaining a healthy weight through appropriate diet and exercise; and 3) OA symptoms can often be significantly reduced without the need for undergoing surgery.
Exercise: The role of physical activity and exercise therapy to reduce symptoms and improve physical function in individuals with knee OA is well-established in the world of research. Current research shows that 150 minutes per week of moderate intensity aerobic exercise or 2 days per week of moderate to vigorous physical activity muscle-strengthening exercises are beneficial for individuals with knee OA. Additionally, more pain reduction was observed when quadriceps-specific exercises were incorporated to exercise routines compared to general lower-limb strengthening exercises and were performed at least 3 times per week. When creating a patient’s exercise program it should focus on patient-centered rehabilitation, consider patient preferences and access to exercise equipment. A key piece that patients should be educated on prior to beginning an exercise program is that pain/discomfort during physical activity does not mean increased structural damage to the joint.
Weight loss: Because of its systemic effects on the body due to inflammatory and metabolic changes, obesity and overweight are considered primary risk factors related to chronic disease, including knee OA. A reduction in weight of approximately 5.1 kilograms (11.22 pounds) decreases the risk of developing knee OA by more than 50% in women with a baseline BMI higher than 25 kg/m2. For individuals with knee OA, a combination of diet and exercise has a moderate effect on relieving pain. After successfully losing weight, maintenance of weight loss remains a substantial challenge. Successful strategies for weight maintenance included creating consecutive weight loss goals, having a regular meal pattern that includes breakfast and healthier eating, having a physically activity lifestyle, and controlling over-eating through self-monitoring behaviors.
Thermal modalities: There is a lack of evidence that supports the use of thermal modalities such as ice packs or moist hot packs in individuals with knee OA.
Laser, therapeutic ultrasound, and electrical stimulation: The Osteoarthritis Research Society International (OARSI) strongly recommends against the use of laser therapy for knee OA. There is currently low-quality evidence that supports the use of therapeutic ultrasound for individuals with knee OA. There is currently very low-quality evidence that supports the use of transcutaneous electrical stimulation in patients with knee OA.
Manual therapy techniques, taping, and acupuncture: There is currently low-level evidence showing that manual therapy techniques provide additional benefit when compared to exercise intervention alone in patients with knee OA. There is very low-level of evidence to support the use of taping for the management of knee OA. When utilizing traditional acupuncture, there is low-level evidence that supports the use of this intervention in patients with knee OA.
Pharmacological strategies
Non-steroidal anti-inflammatory drugs (NSAIDs): Topical NSAIDs are strongly recommended as first-line treatment in both the OARSI and American College of Rheumatology (ACR). OARSI recommends topical NSAIDs for individuals with GI or cardiovascular comorbidities as well as frailty. In addition to topical NSAIDs, the ACR strongly recommends the use of oral NSAIDs and intra-articular glucocorticoid injections.
Opioids: There is high-quality evidence that demonstrates opioids only have small effects on pain and physical function in individuals with knee OA. Additionally, when compared to placebo, patients that used opioids have 3-4 times higher risk of serious adverse effects and/or dropouts due to adverse events.
Nutraceuticals: Nutraceuticals are foods or food supplements that are thought to have health benefits. Glucosamine and chondroitin sulfate are commonly used by patients with knee OA; however, they lack scientific evidence to support their use.
Surgery: Surgery is typically the last resort for knee OA management. There are a wide variety of surgical intervention options available with arthroscopic joint lavage being the most common procedure performed. There are several studies that demonstrate low efficacy of this surgical intervention and the clinical practice guideline published by the Journal of the American Academy of Orthopedic Surgeons strongly recommends against the use of arthroscopy in nearly all patients with degenerative knee disease. Joint replacement surgery is another popular surgery for individuals with end-stage knee OA. Before undergoing this surgery, individuals should trial conservative management for 6 months. If conservative management is unsuccessful in improving symptoms and function, then joint replacement should be considered. However, it is important to note that one in five patients that undergo total knee replacement (TKR) is not satisfied with the outcome. When assessing patients following TKR, it is important for clinicians to measure both self-reported measures and objective measures to comprehensively assess individuals with knee OA.
Take Home Messages:
Knee OA is a degenerative disease that effects a high number of individuals, many of which utilize physical therapy to manage their symptoms and improve their function. It is important for clinicians to stay up to date on evidence-based treatment interventions to provide the best first line care that would most benefit their patients. When it comes to interventions that may not have strong evidence supporting them, if they are interventions that the patient reports pain reduction with, there is little harm in including them into your treatment, however overall treatment should still include evidence-backed intervention like exercise.
Reference:
Dantas, L. O., Salvini, T. F., & McAlindon, T. E. (2021). Knee osteoarthritis: key treatments and implications for physical therapy. Brazilian journal of physical therapy, 25(2), 135–146. https://doi.org/10.1016/j.bjpt.2020.08.004
